Cotempla
RxNorm concept 1926841, brand name (bn).
- RxCUI
- 1926841
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1926841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- methylphenidate 17.3 MG [Cotempla] (SBDC, ingredient of)
- methylphenidate Disintegrating Oral Tablet [Cotempla] (SBDF, ingredient of)
- Cotempla Disintegrating Oral Product (SBDG, ingredient of)
- Cotempla Oral Product (SBDG, ingredient of)
- Cotempla Pill (SBDG, ingredient of)
- methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] (SBD, ingredient of)
- methylphenidate 25.9 MG [Cotempla] (SBDC, ingredient of)
- methylphenidate 25.9 MG Disintegrating Oral Tablet [Cotempla] (SBD, ingredient of)
- methylphenidate 8.6 MG [Cotempla] (SBDC, ingredient of)
- methylphenidate 8.6 MG Disintegrating Oral Tablet [Cotempla] (SBD, ingredient of)
- methylphenidate (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1926841 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1926841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1926841. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.